Torthaí cuardaigh - Vilque, Jean Pierre

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma de réir Faudemer, Julie, Aide, Nicolas, Gac, Anne-Claire, Damaj, Ghandi, Vilque, Jean-Pierre, Lasnon, Charline

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria de réir Quak, Elske, Hovhannisyan, Narinée, Lasnon, Charline, Fruchart, Christophe, Vilque, Jean-Pierre, Musafiri, Dada, Aide, Nicolas

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group de réir Gressin, Rémy, Caulet-Maugendre, Sylvie, Deconinck, Eric, Tournilhac, Olivier, Gyan, Emmanuel, Moles, Marie Pierre, Yamani, Abderrazak El, Cornillon, Jerome, Rossi, Jean François, Le Gouill, Steven, Lepeu, Gérard, Damaj, Ghandi, Celigny, Philippe Solal, Maisonneuve, Hervé, Corront, Bernadette, Vilque, Jean Pierre, Casassus, Philippe, Lamy, Thierry, Colonna, Marc, Colombat, Philippe

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 tri... de réir Rodon, Philippe, Hulin, Cyrille, Pegourie, Brigitte, Tiab, Mourad, Anglaret, Bruno, Benboubker, Lotfi, Jardel, Henry, Decaux, Olivier, Kolb, Brigitte, Roussel, Murielle, Garderet, Laurent, Leleu, Xavier, Fitoussi, Olivier, Chaleteix, Carine, Casassus, Philippe, Lenain, Pascal, Royer, Bruno, Banos, Anne, Benramdane, Riad, Cony-Makhoul, Pascale, Dib, Mamoun, Fontan, Jean, Stoppa, Anne-Marie, Traullé, Catherine, Vilque, Jean-Pierre, Pétillon, Marie-Odile, Mathiot, Claire, Dejoie, Thomas, Avet-Loiseau, Hervé, Moreau, Philippe

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma de réir Gressin, Rémy, Daguindau, Nicolas, Tempescul, Adrian, Moreau, Anne, Carras, Sylvain, Tchernonog, Emmanuelle, Schmitt, Anna, Houot, Roch, Dartigeas, Caroline, Pignon, Jean Michel, Corm, Selim, Banos, Anne, Mounier, Christiane, Dupuis, Jehan, Macro, Margaret, Fleury, Joel, Jardin, Fabrice, Sarkozy, Clementine, Damaj, Ghandi, Feugier, Pierre, Fornecker, Luc Matthieu, Chabrot, Cecile, Dorvaux, Veronique, Bouadallah, Krimo, Amorin, Sandy, Garidi, Reda, Voillat, Laurent, Joly, Bertrand, Celigny, Philippe Solal, Morineau, Nadine, Moles, Marie Pierre, Zerazhi, Hacene, Fontan, Jean, Arkam, Yazid, Alexis, Magda, Delwail, Vincent, Vilque, Jean Pierre, Ysebaert, Loic, Le Gouill, Steven, Callanan, Mary B.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán